Difference between revisions of "Enzalutamide"
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
==See also== | ==See also== | ||
*[[Abiraterone]]. | *[[Abiraterone]]. | ||
*[[Androgen receptor]]. | |||
==References== | ==References== | ||
Latest revision as of 13:11, 18 March 2019
Enzalutamide is an androgen receptor antagonist used to treat prostate cancer.[1]
See also
References
- ↑ Mitsiades, N. (Aug 2013). "A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer.". Cancer Res 73 (15): 4599-605. doi:10.1158/0008-5472.CAN-12-4414. PMID 23887973.